Lazard Asset Management
IRMD icon

Lazard Asset Management’s iRadimed IRMD Stock Holding History

Lazard Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Sell
48,715
-199
-0.4% -$18.1K 0.01% 641
2026
Q1 		$4.71M Buy
48,914
+6,524
+15% +$652K 0.01% 577
2025
Q4 		$4.12M Buy
42,390
+2,216
+6% +$190K 0.01% 612
2025
Q3 		$2.86M Sell
40,174
-936
-2% -$62.4K ﹤0.01% 746
2025
Q2 		$2.46M Buy
41,110
+2,036
+5% +$112K ﹤0.01% 943
2025
Q1 		$2.05M Buy
39,074
+5,782
+17% +$325K ﹤0.01% 965
2024
Q4 		$1.83M Buy
33,292
+8,773
+36% +$462K ﹤0.01% 916
2024
Q3 		$1.23M Buy
24,519
+9,005
+58% +$415K ﹤0.01% 1016
2024
Q2 		$681K Buy
15,514
+9,406
+154% +$400K ﹤0.01% 1089
2024
Q1 		$268K Sell
6,108
-210
-3% -$9.28K ﹤0.01% 1207
2023
Q4 		$299K Buy
6,318
+293
+5% +$12.3K ﹤0.01% 1260
2023
Q3 		$267K Buy
6,025
+827
+16% +$38.4K ﹤0.01% 1290
2023
Q2 		$248K Buy
5,198
+143
+3% +$6.45K ﹤0.01% 1287
2023
Q1 		$198K Sell
5,055
-637
-11% -$23.2K ﹤0.01% 1314
2022
Q4 		$161K Buy
5,692
+12
+0.2% +$343 ﹤0.01% 1346
2022
Q3 		$170K Sell
5,680
-44
-0.8% -$1.53K ﹤0.01% 1307
2022
Q2 		$194K Buy
5,724
+3,593
+169% +$129K ﹤0.01% 1293
2022
Q1 		$95K Buy
2,131
+68
+3% +$3.15K ﹤0.01% 1414
2021
Q4 		$95K Buy
+2,063
New +$83.2K ﹤0.01% 1460
2021
Q3 		– Sell
-824
Closed -$24K – 2217
2021
Q2 		$24K Buy
+824
New +$22.7K ﹤0.01% 1837
2021
Q1 		– Sell
-649
Closed -$14K – 1928
2020
Q4 		$14K Sell
649
-151
-19% -$3.49K ﹤0.01% 1751
2020
Q3 		$17K Sell
800
-1,015
-56% -$22.8K ﹤0.01% 1445
2020
Q2 		$42K Sell
1,815
-278
-13% -$5.97K ﹤0.01% 1275
2020
Q1 		$44K Buy
2,093
+1,357
+184% +$32.3K ﹤0.01% 1221
2019
Q4 		$17K Buy
736
+296
+67% +$6.92K ﹤0.01% 1270
2019
Q3 		$9K Buy
+440
New +$8.98K ﹤0.01% 1318

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management's IRMD Position: Q2 2026 in Review

Lazard Asset Management reduced its iRadimed (IRMD) stake by 0.41% in Q2 2026, selling an estimated $18.1K and leaving 48,715 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #641.

Lazard Asset Management first reported a position in IRMD in Q3 2019 and has held it in 26 quarters since. The position peaked at $4.71M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Lazard Asset Management held 48,715 shares of iRadimed worth $4.66M as of Q2 2026.
  • Lazard Asset Management sold 199 iRadimed shares in Q2 2026, an estimated $18.1K.
  • iRadimed made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #641 holding.
  • Lazard Asset Management first reported a position in iRadimed in Q3 2019 and has held it in 26 quarters since.
  • Lazard Asset Management's iRadimed position peaked at $4.71M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.